Showing results (911-920 of 1,000) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|October 17, 2013
High-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell linesPaul A Johnston, Malabika Sen, Yun Hua, et al.
Assay and Drug Development Technologies|October 17, 2013
Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitorsTakrima Sadikot, Megan Swink, Jeffery D Eskew, et al.
Assay and Drug Development Technologies|November 16, 2013
A fluorescence anisotropy-based Myt1 kinase binding assayAlexander Rohe, Claudia Henze, Frank Erdmann, et al.
Assay and Drug Development Technologies|August 3, 2013
A time-resolved fluorescence resonance energy transfer assay for high-throughput screening of 14-3-3 protein-protein interaction inhibitorsYuhong Du, Robert W Fu, Bin Lou, et al.
Assay and Drug Development Technologies|August 3, 2013
A highly specific cell-based high-throughput screening assay for ligands of cyclic adenosine monophosphate receptor protein in gram-negative bacteriaHongxia Wang, Anisia J Silva, Lynn Rasmussen, et al.
Assay and Drug Development Technologies|December 24, 2011
Characterization of ligand binding to the σ(1) receptor in a human tumor cell line (RPMI 8226) and establishment of a competitive receptor binding assayStefanie Brune, Dirk Schepmann, Kirstin Lehmkuhl, et al.
Assay and Drug Development Technologies|November 6, 2015
High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and HepatocytesFabian Alexander Grimm, Yasuhiro Iwata, Oksana Sirenko, et al.
Assay and Drug Development Technologies|August 25, 2017
Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac SpheroidsOksana Sirenko, Michael K Hancock, Carole Crittenden, et al.
Assay and Drug Development Technologies|August 25, 2017
Improving Comprehension Efficiency of High Content Screening Data Through Interactive VisualizationsWienand A Omta, Jacob de Nobel, Judith Klumperman, et al.
Assay and Drug Development Technologies|July 9, 2016
Neuroprotective Properties of a Macrolide Antibiotic in a Mouse Model of Middle Cerebral Artery Occlusion: Characterization of the Immunomodulatory Effects and Validation of the Efficacy of Intravenous AdministrationDiana Amantea, Michelangelo Certo, Francesco Petrelli, et al.
Pageof 100